CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a serum-based assay kit, DiviTum™, to detect Thymidine Kinase activity, a biomarker for cancer treatment. It aims to improve patient treatment selection and clinical trial success rates for drugs targeting cell cycle regulation, particularly Cyclin Dependent Kinase inhibitors.
The traditionally practiced approach to cancer therapy and development of new cancer drugs is to treat a large pool of patients as potential responders.
This results in patients not receiving the optimal treatment; payers paying for treatments that do not benefit patients; drug developers facing higher risk of regulatory failure due to not being able to use better tools for selection of patients in the clinical development program; and clinicians lacking predictive and monitoring tools to admini…
BIOVICA INTERNATIONAL AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
